Cargando…
Unveiling the “Template-Dependent” Inhibition on the Viral Transcription of SARS-CoV-2
[Image: see text] Remdesivir is one nucleotide analogue prodrug capable to terminate RNA synthesis in SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) by two distinct mechanisms. Although the “delayed chain termination” mechanism has been extensively investigated, the “template-dependent” inhibitory m...
Autores principales: | Luo, Xueying, Wang, Xiaowei, Yao, Yuan, Gao, Xin, Zhang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363016/ https://www.ncbi.nlm.nih.gov/pubmed/35912566 http://dx.doi.org/10.1021/acs.jpclett.2c01314 |
Ejemplares similares
-
A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021) -
Duplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS – CoV-2
por: D’Souza, Aaron R., et al.
Publicado: (2021) -
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
por: Zu, Shulong, et al.
Publicado: (2021) -
Exploring Viral Metagenomics in Pediatric Patients with Acute Respiratory Infections: Unveiling Pathogens beyond SARS-CoV-2
por: de Campos, Gabriel Montenegro, et al.
Publicado: (2023) -
Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study
por: Bai, Bingke, et al.
Publicado: (2021)